CETP Inhibition: Past Failures and Future Hopes

Por Kosmas, Constantine E., DeJesus, Eddy, Rosario, Digna, Vittorio, Timothy J.
Publicado no Clin Med Insights Cardiol (2016)

Lipid-lowering interventions targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): an emerging chapter in lipid-lowering therapy

Por Kosmas, Constantine E, DeJesus, Eddy, Morcelo, Rosmery, Garcia, Frank, Montan, Peter D, Guzman, Eliscer
Publicado no Drugs Context (2017)

Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition with evolocumab: powerful low-density lipoprotein cholesterol (LDL-C) lowering and improved cardiovascular outcomes...

Por Kosmas, Constantine E., Sourlas, Andreas, Bouza, Kyriaki V., DeJesus, Eddy, Silverio, Delia, Montan, Peter D., Guzman, Eliscer
Publicado no Ann Transl Med (2018)